Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?

被引:86
|
作者
Caro, Jaime J. [1 ,2 ]
Moeller, Joergen [3 ]
Getsios, Denis [4 ]
机构
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Div Gen Internal Med, Montreal, PQ, Canada
[2] United BioSource Corp, Lexington, MA USA
[3] UnitedBioSource Corp, Eslov, Sweden
[4] UnitedBioSource Corp, Halifax, NS, Canada
关键词
decision tree; discrete event simulation; economic evaluation; Markov; modeling; PHARMACOECONOMICS; MODEL; CARE;
D O I
10.1111/j.1524-4733.2010.00775.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: To argue that discrete event simulation should be preferred to cohort Markov models for economic evaluations in health care. Methods: The basis for the modeling techniques is reviewed. For many health-care decisions, existing data are insufficient to fully inform them, necessitating the use of modeling to estimate the consequences that are relevant to decision-makers. These models must reflect what is known about the problem at a level of detail sufficient to inform the questions. Oversimplification will result in estimates that are not only inaccurate, but potentially misleading. Results: Markov cohort models, though currently popular, have so many limitations and inherent assumptions that they are inadequate to inform most health-care decisions. An event-based individual simulation offers an alternative much better suited to the problem. A properly designed discrete event simulation provides more accurate, relevant estimates without being computationally prohibitive. It does require more data and may be a challenge to convey transparently, but these are necessary trade-offs to provide meaningful and valid results. Conclusion: In our opinion, discrete event simulation should be the preferred technique for health economic evaluations today.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [1] Advantages and disadvantages of discrete-event simulation for health economic analyses
    Caro, J. Jaime
    Moller, Jorgen
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (03) : 327 - 329
  • [2] Discrete-event simulation models in the economic evaluation of health technologies and health products
    Rodriguez Barrios, Jose Manuel
    Serrano, David
    Monleon, Ton
    Caro, Jaime
    GACETA SANITARIA, 2008, 22 (02) : 151 - 161
  • [3] About the advantages and disadvantages of discrete-event simulation for health economic analyses
    Toumi, Mondher
    Beck, Ekkehard
    Sherman, Steve
    Mohseninejad, Leyla
    Aballea, Samuel
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 651 - 652
  • [4] A discrete event simulation model simplification technique
    Johnson, RT
    Fowler, JW
    Mackulak, GT
    PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, 2005, : 2172 - 2176
  • [5] Economic advantages of online discrete event simulation training
    Hunting, B.
    Moller, J.
    VALUE IN HEALTH, 2007, 10 (06) : A459 - A460
  • [6] Discrete event simulation in the health policy and management program
    Groothuis, S
    van Merode, GG
    METHODS OF INFORMATION IN MEDICINE, 2000, 39 (4-5) : 339 - 342
  • [7] A conceptual modeling technique for discrete event simulation of operational processes
    Pels, Henk Jan
    Goossenaerts, Jan
    ADVANCES IN PRODUCTION MANAGEMENT SYSTEMS, 2007, 246 : 305 - +
  • [8] Reply: Letter to the Editor: About the advantages and disadvantages of discrete-event simulation for health economic analyses
    Caro, J. Jaime
    Moller, Jorgen
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 653 - 653
  • [9] A DISCRETE EVENT SIMULATION MODEL TO ESTIMATE POPULATION LEVEL HEALTH AND ECONOMIC IMPACTS OF SMOKING CESSATION INTERVENTIONS
    Mayorga, Maria E.
    Reifsnider, Odette S.
    Wheeler, Stephanie B.
    Kohler, Racquel E.
    PROCEEDINGS OF THE 2014 WINTER SIMULATION CONFERENCE (WSC), 2014, : 1257 - 1268
  • [10] Discrete Event Simulation
    Jacob, Matthew
    RESONANCE-JOURNAL OF SCIENCE EDUCATION, 2013, 18 (01): : 78 - 86